The association of exercise test variables with long-term mortality in patients with chronic Chagas disease

被引:1
|
作者
Silva, Rudson S. [1 ]
Mendes, Fernanda S. N. S. [1 ]
Fleg, Jerome L. [2 ]
Rodrigues Junior, Luiz F. [3 ]
Vieira, Marcelo C. [1 ,4 ]
Xavier, Isis G. G. [1 ]
Costa, Henrique S. [5 ]
Reis, Michel S. [6 ]
Mazzoli-Rocha, Flavia [1 ]
Costa, Andrea R. [1 ]
Holanda, Marcelo T. [1 ]
Veloso, Henrique H. [1 ]
Sperandio da Silva, Gilberto M. [1 ]
Sousa, Andrea S. [1 ]
Saraiva, Roberto M. [1 ]
Hasslocher-Moreno, Alejandro Marcel [1 ]
Mediano, Mauro F. F. [1 ,3 ]
机构
[1] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil
[2] Natl Heart Lung & Blood Inst, NIH, Bethesda, MD USA
[3] Natl Inst Cardiol, Dept Res & Educ, Rio De Janeiro, RJ, Brazil
[4] Aloysio Castro State Inst Cardiol, Ctr Cardiol & Exercise, Rio De Janeiro, RJ, Brazil
[5] Fed Univ Jequitinhonha & Mucuri Valleys, Phys Therapy Dept, Diamantina, MG, Brazil
[6] Univ Fed Rio de Janeiro, Fac Phys Therapy, Sch Med, Rio De Janeiro, RJ, Brazil
关键词
Chagas disease; mortality; prognosis; VO(2)max; maximal functional capacity; CARDIOPULMONARY EXERCISE; VENTRICULAR-TACHYCARDIA; BLOOD-PRESSURE; HEART-FAILURE; PREDICTOR; CARDIOMYOPATHY; DEATH; ELECTROCARDIOGRAM; STANDARDS; CAPACITY;
D O I
10.3389/fmed.2022.972514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe identification of variables obtained in the exercise test (ET) associated with increased risk of death is clinically relevant and would provide additional information for the management of Chagas disease (CD). The objective of the present study was to evaluate the association of ET variables with mortality in patients with chronic CD. MethodsThis retrospective longitudinal observational study included 232 patients (median age 46.0 years; 50% women) with CD that were followed at the Evandro Chagas National Institute of Infectious Diseases (Rio de Janeiro, Brazil) and performed an ET between 1989 and 2000. The outcome of interest was all-cause mortality. ResultsThere were 103 deaths (44.4%) during a median follow-up of 21.5 years (IQR 25-75% 8.0-27.8), resulting in 24.5 per 1,000 patients/year incidence rate. The ET variables associated with mortality after adjustments for potential confounders were increased maximal (HR 1.02; 95% CI 1.00-1.03 per mmHg) and change (HR 1.03; 95% CI 1.01-1.06 per mmHg) of diastolic blood pressure (DBP) during ET, ventricular tachycardia at rest (HR 3.95; 95% CI 1.14-13.74), during exercise (HR 2.73; 95% CI 1.44-5.20), and recovery (HR 2.60; 95% CI 1.14-5.91), and premature ventricular complexes during recovery (HR 2.06; 1.33-3.21). ConclusionOur findings suggest that ET provides important prognostic value for mortality risk assessment in patients with CD, with hemodynamic (increased DBP during exercise) and electrocardiographic (presence of ventricular arrhythmias) variables independently associated with an increased mortality risk in patients with CD. The identification of individuals at higher mortality risk can facilitate the development of intervention strategies (e.g., close follow-up) that may potentially have an impact on the longevity of patients with CD.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Galectin-3 Associated with Severe Forms and Long-term Mortality in Patients with Chagas Disease
    Fernandes, Fabio
    Valente Moreira, Carlos Henrique
    Oliveira, Lea Campos
    Souza-Basqueira, Marcela
    Ianni, Barbara Maria
    di Lorenzo, Claudia
    Alvarez Ramires, Felix Jose
    Nastari, Luciano
    Cunha-Neto, Edecio
    Ribeiro, Antonio L.
    Lopes, Renato Delascio
    Keating, Sheila M.
    Sabino, Ester Cerdeira
    Mady, Charles
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (02) : 248 - 256
  • [2] Cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy: long-term follow up
    de Araujo, Edgard Ferreira
    Chamlian, Eduardo Gregorio
    Peroni, Alexey Pomares
    Pereira, Wilson Lopes
    de Aquino Gandra, Sylvio Matheus
    Rivetti, Luiz Antonio
    REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2014, 29 (01): : 31 - 36
  • [3] Prevalence and clinical course of patients with chronic heart failure secondary to chronic Chagas heart disease associated with obstructive coronary artery disease
    Otaviano, Ana Paula
    Cardinalli-Neto, Augusto
    Nakazone, Marcelo A.
    Nogueira, Paulo R.
    Bestetti, Reinaldo B.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2023, 117 (04) : 279 - 284
  • [4] Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease
    Benchimol-Barbosa, P. R.
    Barbosa-Filho, J.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (03) : 251 - 262
  • [5] Cardiopulmonary exercise and 6-min walk tests as predictors of quality of life and long-term mortality among patients with heart failure due to Chagas disease
    Ritt, Luiz Eduardo
    Carvalho, Antonio Carlos
    Feitosa, Gilson Soares
    Pinho-Filho, Joel A.
    Santos Andrade, Marcus Vinicius
    Feitosa-Filho, Gilson Soares
    Newby, L. Kristin
    Lopes, Renato D.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4584 - 4585
  • [6] The Impact of Anemia on Long-Term Mortality in Hospitalized Patients with Exacerbation of Chronic Obstructive Pulmonary Disease
    Garcia-Pachon, Eduardo
    Padilla-Navas, Isabel
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 2229 - 2237
  • [7] Clinical and functional variables associated to long-term mortality in COPD patients
    Saldias, Fernando
    Gassmann, Javiera
    Canelo, Alejandro
    Diaz, Orlando
    REVISTA MEDICA DE CHILE, 2018, 146 (04) : 422 - 432
  • [8] Association of peripheral artery disease and long-term mortality in hemodialysis patients
    Otsubo, Shigeru
    Kitamura, Mariko
    Wakaume, Takako
    Yajima, Aiji
    Ishihara, Miwa
    Takasaki, Masayo
    Ueda, Syuitsu
    Sugimoto, Hisayuki
    Otsubo, Kimiko
    Kimata, Naoki
    Akiba, Takashi
    Nitta, Kosaku
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 569 - 573
  • [9] Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study
    Hasslocher-Moreno, Alejandro M.
    Saraiva, Roberto M.
    Sangenis, Luiz H. C.
    Xavier, Sergio S.
    de Sousa, Andrea S.
    Costa, Andrea R.
    de Holanda, Marcelo T.
    Veloso, Henrique H.
    Mendes, Fernanda S. N. S.
    Costa, Filipe A. C.
    Boia, Marcio N.
    Brasil, Pedro E. A. A.
    Carneiro, Fernanda M.
    Sperandio da Silva, Gilberto M.
    Mediano, Mauro F. F.
    ECLINICALMEDICINE, 2021, 31
  • [10] Improvement of clinic and serological long-term evolution of chronic Chagas disease patients treated with benznidazole
    Viotti, Rodolfo
    Vigliano, Carlos
    Lococo, Bruno
    Bertocchi, Graciela
    Petti, Marcos
    Gabriela Alvarez, Maria
    Armenti, Alejandro
    SALUD I CIENCIA, 2009, 16 (08): : 855 - 859